Hikma Buys Injectables Specialist Custopharm In $400m+ Deal
Deal To Acquire California-Based Firm Will Bolster Hikma’s US Injectables Business
• By David Wallace
Hikma has agreed a $400m+ deal for sterile injectables specialist Custopharm • Source: Alamy 
